Spinal Modulation (Menlo Park, CA) a development-stage medical device company focused on a spinal cord stimulator system for treating chronic intractable pain, closed a $27.4M Series C financing. Participants include Johnson & Johnson Development Corp., DFJ InCube Ventures, Raffles Venture Partners, DeNovo Ventures, DFJ ePlanet, Kleiner Perkins Caufield & Byers and MedVenture.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb